MAP2K7 and melanoma: To exclude increased drug efflux underlying YAP5SA-mediated MAPKi resistance, we assessed MEK phosphorylation in YAP5SA melanoma cell lines, as efficient BRAFV600E inhibition was expected to reduce MEK phosphorylation.